Evidence map›Paper›PMID 39331131›Full record

Observational studyEuropean journal of nuclear medicine and molecular imaging2025

Utility of pre-procedural [

Marnix Lam, Etienne Garin, Paul Haste, Alban Denys, Brian Geller, S Cheenu Kappadath, Cuneyt Turkmen, Daniel Y Sze, Hamad Saleh Alsuhaibani, Ken Herrmann and 6 more

Registry-linked trialAbstract readComparative StudyMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03295006 (A TheraSphere® Advanced Dosimetry Retrospective Global Study Evaluation in Hepatocellular Carcinoma Treatment), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03295006 completednot on this map

A TheraSphere® Advanced Dosimetry Retrospective Global Study Evaluation in Hepatocellular Carcinoma Treatment

TypeobservationalSponsorBoston Scientific CorporationRan2016 to 2020Enrolled209ConditionsHepatocellular CarcinomaArmsTheraSphere
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Predictive value of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marnix LamDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht, Huispostnummer E01.132. Postbus 85500, Utrecht, 3508 GA, The Netherlands. m.lam@umcutrecht.nl.ORCID 0000-0002-4902-9790
Etienne GarinNuclear Medicine Department, Eugene Marquis Center, Rennes, France.
Paul HasteDepartment of Clinical Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.
Alban DenysDepartment of Radiology and Interventional Radiology, Lausanne University Hospital CHUV, University of Lausanne, Lausanne, Switzerland.
Brian GellerDepartment of Radiology, University of Florida, Gainesville, FL, USA.
S Cheenu KappadathDepartment of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cuneyt TurkmenDepartment of Nuclear Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Daniel Y SzeDivision of Interventional Radiology, Stanford University, Stanford, CA, USA.
Hamad Saleh AlsuhaibaniDepartment of Radiology, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Ken HerrmannDepartment of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (TKTK)-University Hospital Essen, Essen, Germany.
Marco MaccauroNuclear Medicine Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Murat CantasdemirDivision of Interventional Radiology, Istanbul Florence Nightingale Hospital, Istanbul, Turkey.
Matthew DreherBoston Scientific Corporation, Marlborough, MA, USA.
Kirk D FowersBoston Scientific Corporation, Marlborough, MA, USA.
Vanessa GatesDepartment of Radiology, Northwestern Feinberg School of Medicine, Chicago, IL, USA.
Riad SalemDepartment of Radiology, Northwestern Feinberg School of Medicine, Chicago, IL, USA.

Funding

BTG International/Boston Scientific Corporation BTG International/Boston Scientific Corporation
6 · The paper itself

Abstract

purposePre-treatment [ MATERIALS AND

methodsIncluded patients had HCC treated by glass [

resultsA total of 209 patients were enrolled. Total perfused tumor and normal tissue volumes were larger when using anatomic versus [

conclusionReal-world data support [ TRIAL REGISTRATION NUMBER: NCT03295006.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMicrospheresRadiotherapy Planning, Computer-AssistedSingle Photon Emission Computed Tomography Computed TomographyTechnetium Tc 99m Aggregated AlbuminYttrium RadioisotopesAdultAgedAged, 80 and overAlbuminsFemaleGlassHumansMaleMiddle AgedAlbuminsmacro aggregates of albuminTechnetium Tc 99m Aggregated AlbuminYttrium-90Yttrium RadioisotopesDosimetryHepatocellular carcinomaRadioembolizationSegmentationYttrium-90

Identifiers

PMID39331131
PMCPMC11732885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.